Onychomycosis: An Updated Review
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Background : Onychomycosis is a common fungal infection of the nail. Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis. Methods: A PubMed search was completed in Clinical Queries using the key term “onychomycosis”. The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews published within the past 20 years. The search was restricted to English literature. Patents were searched using the key term “onychomycosis” in www.freepatentsonline.com. Results : Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays. Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the management of onychomycosis are also discussed. Conclusion: Oral antifungal therapies are effective, but significant adverse effects limit their use. Although topical antifungal therapies have minimal adverse events, they are less effective than oral antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective and/or alternative treatment modalities for the treatment of onychomycosis which are safer and more effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghannoum, M. A., Hajjeh, R. A., Scher, R., Konnikov, N., Gupta, A. K., Summerbell, R., Sullivan, S., Daniel, R., Krusinski, P., Fleckman, P., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107754 · Cited by 534
Lipner, S. R., & Scher, R. K. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.062 · Cited by 345 · cited 11×
“concomitant toenail involvement unless the patient is immunocompromised or there is a history of trauma [14].”
BackgroundInfluentialREVIEW ARTICLE: Toenail onychomycosis: an important global disease burden
Thomas, J., Jacobson, G. A., Narkowicz, C. K., Peterson, G. M., Burnet, H., & Sharpe, C. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01107.x · Cited by 327
Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment
Gupta, A. K., Versteeg, S. G., & Shear, N. H. (2017) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475417716362 · Cited by 268
Onychomycosis: Current trends in diagnosis and treatment.
Westerberg, D. P., & Voyack, M. J. (2013) · PubMed · Cited by 243
British Association of Dermatologists' guidelines for the management of onychomycosis 2014
Ameen, M., Lear, J. T., Madan, V., Mohd Mustapa, M. F., Richardson, M., Hughes, J. R., Sahota, A., Griffiths, M., McDonagh, A. J., Punjabi, S., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13358 · Cited by 243
Lipner, S. R., & Scher, R. K. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.05.1260 · Cited by 243 · cited 10×
“Endonyx onychomycosis is caused by fungal infection of the nail plate without infection of the nail bed [14, 28, 53, 63].”
BackgroundInfluentialThe prevalence of onychomycosis in the global population – A literature study
Sigurgeirsson, B., & Baran, R. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12323 · Cited by 218
Anti-biofilm properties of chitosan-coated surfaces
Carlson, R. P., Taffs, R., Davison, W. M., & Stewart, P. S. (2008) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856208784909372 · Cited by 213
Onychomycosis: Diagnosis and definition of cure
Scher, R. K., Tavakkol, A., Sigurgeirsson, B., Hay, R. J., Joseph, W. S., Tosti, A., Fleckman, P., Ghannoum, M., Armstrong, D. G., Markinson, B. C., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.019 · Cited by 187
Research works printed but not linked: 105
- Hoy N.Y.; Leung A.K.; Metelitsa A.I.; Adams S.; New concepts in median nail dystrophy, onychomycosis, and hand, foot, and mouth disease nail pathology. ISRN Dermatol 2012,2012 · doi:10.5402/2012/680163
- Vlahovic T.C.; Onychomycosis: Evaluation, treatment options, managing recurrence, and patient outcomes. Clin Podiatr Med Surg 2016,33(3),305-318 · doi:10.1016/j.cpm.2016.02.001
- Queller J.N.; Bhatia N.; The dermatologist’s approach to onychomycosis. J Fungi (Basel) 2015,1(2),173-184 · doi:10.3390/jof1020173
- Gupta A.K.; Mays R.R.; Versteeg S.G.; Shear N.H.; Piguet V.; Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther 2018,16(12),929-938 · doi:10.1080/14787210.2018.1544891
- Gupta A.K.; Sibbald R.G.; Andriessen A.; Belley R.; Boroditsky A.; Botros M.; Toenail onychomycosis - A Canadian approach with a new transungual treatment: Development of a clinical pathway. J Cutan Med Surg 2015,19(5),440-449 · doi:10.1177/1203475415581310
- Joyce A.; Gupta A.K.; Koenig L.; Wolcott R.; Carviel J.; Fungal diversity and onychomycosis: An analysis of 8,816 toenail samples using quantitative PCR and next-generation sequencing. J Am Podiatr Med Assoc 2019,109(1),57-63 · doi:10.7547/17-070
- Youssef A.B.; Kallel A.; Azaiz Z.; Jemel S.; Bada N.; Chouchen A.; Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis. J Mycol Med 2018,28(4),651-654 · doi:10.1016/j.mycmed.2018.07.005
- Fike J.M.; Kollipara R.; Alkul S.; Stetson C.L.; Case report of onychomycosis and tinea corporis due to Microsporum gypseum. J Cutan Med Surg 2018,22(1),94-96 · doi:10.1177/1203475417724439
- Pang S.M.; Pang J.Y.Y.; Fook-Chong S.; Tan A.L.; Tinea unguium onychomycosis caused by dermatophytes: A ten-year (2005-2014) retrospective study in a tertiary hospital in Singapore. Singapore Med J 2018,59(10),524-527 · doi:10.11622/smedj.2018037
- Sato T.; Kitahara H.; Honda H.; Katsukawa F.; Hiruma M.; Yaguchi T.; Onychomycosis of the middle finger of a Japanese judo athlete due to Trichophyton tonsurans. Med Mycol J 2019,60(1),1-4 · doi:10.3314/mmj.18-00012
- Solís-Arias M.P.; García-Romero M.T.; Onychomycosis in children. A review. Int J Dermatol 2017,56(2),123-130 · doi:10.1111/ijd.13392
- Hirose M.; Noguchi H.; Yaguchi T.; Matsumoto T.; Hiruma M.; Fukushima S.; Onychomycosis caused by Aspergillus subramanianii. J Dermatol 2018,45(11),1362-1366 · doi:10.1111/1346-8138.14616
- Hon K.L.; Leung A.K.; Alopecia areata. Recent Pat Inflamm Allergy Drug Discov 2011,5(2),98-107 · doi:10.2174/187221311795399291
- Kimura U.; Hiruma M.; Kano R.; Matsumoto T.; Takamori K.; Suga Y.; Onychomycosis caused by Scopulariopsis brevicaulis: The third documented case in Japan. J Dermatol 2019,46(5),e167-e168 · doi:10.1111/1346-8138.14677
- Matsuyama Y.; Nakamura T.; Hagi T.; Asanuma K.; Sudo A.; Subungual onychomycosis due to Aspergillus niger mimicking a glomus tumor: A case report. Biomed Rep 2017,7(6),532-534 · doi:10.3892/br.2017.994
- Mohanty P.; Dash S.; Mohapatra L.; Jain M.; Total dystrophic onychomycosis due to Syncephalastrum racemosum - A rare cause and its novel treatment option. Indian Dermatol Online J 2019,10(2),171-173 · doi:10.4103/idoj.idoj_155_18
- Moreno G.; Arenas R.; Other fungi causing onychomycosis. Clin Dermatol 2010,28(2),160-163 · doi:10.1016/j.clindermatol.2009.12.009
- Noguchi H.; Hiruma M.; Miyashita A.; Makino K.; Miyata K.; Ihn H.; A case of fingernail onychomycosis due to Aspergillus flavus. Med Mycol J 2016,57(2),E21-E25 · doi:10.3314/mmj.57.e21
- Piraccini B.M.; Alessandrini A.; Onychomycosis: A review. J Fungi (Basel) 2015,1(1),30-43 · doi:10.3390/jof1010030
- Pontini P.; Gorani A.; Veraldi S.; Onychomycosis by Paecilomyces lilacinus. G Ital Dermatol Venereol 2016,151(6),706-709
- Pote S.T.; Khan U.; Lahiri K.K.; Patole M.S.; Thakar M.R.; Shah S.R.; Onychomycosis due to Achaetomium strumarium. J Mycol Med 2018,28(3),510-513 · doi:10.1016/j.mycmed.2018.07.002
- Veiga F.F.; de Castro-Hoshino L.V.; Sato F.; Bombassaro A.; Vicente V.A.; Mendes V.; Fusarium oxysporum is an onychomycosis etiopathogenic agent. Future Microbiol 2018,13,1745-1756 · doi:10.2217/fmb-2018-0245
- Ge G.; Yang Z.; Li D.; Sybren de Hoog G.; Shi D.; Onychomycosis with greenish-black discolorations and recurrent onycholysis caused by Candida parapsilosis. Med Mycol Case Rep 2019,24,48-50 · doi:10.1016/j.mmcr.2019.04.005
- Seebacher C.; Brasch J.; Abeck D.; Cornely O.; Effendy I.; Ginter-Hanselmayer G.; Onychomycosis. J Dtsch Dermatol Ges 2007,5(1),61-66 · doi:10.1111/j.1610-0387.2007.06134.x
- Goldstein A.O.; Bhatia N.; Onychomycosis: Epidemiology, clinical features, and diagnosis. Post TW, edUp To Date Waltham, MA. (Accessed on June 30, 2019).
- Cozzani E.; Agnoletti A.F.; Speziari S.; Schiavetti I.; Zotti M.; Persi A.; Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int 2016,16(4),486-491 · doi:10.1111/ggi.12496
- Gupta A.K.; Studholme C.; Update on efinaconazole 10% topical solution for the treatment of onychomycosis. Skin Therapy Lett 2016,21(6),7-11
- Rosen T.; Friedlander S.F.; Kircik L.; Zirwas M.J.; Stein Gold L.; Bhatia N.; Onychomycosis: Epidemiology, diagnosis, and treatment in a changing landscape. J Drugs Dermatol 2015,14(3),223-233
- Rosen T.; Tinea and onychomycosis. Semin Cutan Med Surg 2016,35(Suppl. 6),S110-S113 · doi:10.12788/j.sder.2016.035
- Allevato M.A.; Diseases mimicking onychomycosis. Clin Dermatol 2010,28(2),164-177 · doi:10.1016/j.clindermatol.2009.12.001
- Assadamongkol R.; Lertwattanarak R.; Wannachalee T.; Bunyaratavej S.; Leeyaphan C.; Matthapan L.; Prevalence, risk factors, and type of organism in fungal foot infection and toenail onychomycosis in Thai diabetic patients. J Med Assoc Thai 2016,99(6),659-664
- Cathcart S.; Cantrell W.; Elewski Be.; Onychomycosis and diabetes. J Eur Acad Dermatol Venereol 2009,23(10),1119-1122 · doi:10.1111/j.1468-3083.2009.03225.x
- Daggett C.; Brodell R.T.; Daniel C.R.; Jackson J.; Onychomycosis in athletes. Am J Clin Dermatol 2019,20(5),691-698 · doi:10.1007/s40257-019-00448-4
- Gallo L.; Cinelli E.; Fabbrocini G.; Vastarella M.; A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. Mycoses 2019,62(8),659-664 · doi:10.1111/myc.12925
- Gómez-Moyano E.; Crespo-Erchiga V.; HIV infection manifesting as proximal white onychomycosis. N Engl J Med 2017,377(18) · doi:10.1056/nejmicm1703082
- Jimenez-Gonzalez C.; Mata-Marin J.A.; Arroyo-Anduiza C.I.; Ascencio-Montiel Ide J.; Fuentes-Allen J.L.; Gaytan-Martinez J.; Prevalence and etiology of onychomycosis in the HIV-infected Mexican population. Eur J Dermatol 2013,23(3),378-381 · doi:10.1684/ejd.2013.2015
- Shemer A.; Gupta A.K.; Amichai B.; Baum S.; Barzilai A.; Farhi R.; Increased risk of tinea pedis and onychomycosis among swimming pool employees in Netanya area, Israel. Mycopathologia 2016,181(11-12),851-856 · doi:10.1007/s11046-016-0040-5
- Tabassum S.; Rahman A.; Awan S.; Jabeen K.; Farooqi J.; Ahmed B.; Factors associated with onychomycosis in nail psoriasis: A multicenter study in Pakistan. Int J Dermatol 2019,58(6),672-678 · doi:10.1111/ijd.14364
- Grover C.; Khurana A.; Onychomycosis: Newer insights in pathogenesis and diagnosis. Indian J Dermatol Venereol Leprol 2012,78(3),263-270 · doi:10.4103/0378-6323.95440
- Monteagudo B.; Figueroa O.; Suárez-Magdalena O.; Méndez-Lage S.; Green nail caused by onychomycosis coinfected with Pseudomonas aeruginosa. Actas Dermosifiliogr 2019,110(9),783-785 · doi:10.1016/j.adengl.2018.04.023
- Akhtar N.; Sharma H.; Pathak K.; Onychomycosis: Potential of nail lacquers in transungual delivery of antifungals. Scientifica (Cairo) 2016,2016 · doi:10.1155/2016/1387936
- Gupta A.K.; Mays R.R.; Versteeg S.G.; Piraccini B.M.; Takwale A.; Shemer A.; Global perspectives for the management of onychomycosis. Int J Dermatol 2019,58(10),1118-1129 · doi:10.1111/ijd.14346
- Shemer A.; Update: Medical treatment of onychomycosis. Dermatol Ther 2012,25(6),582-593 · doi:10.1111/j.1529-8019.2012.01551.x
- Gupta A.K.; Versteeg S.G.; Shear N.H.; Confirmatory testing prior to treating toenail onychomycosis is recommended in Canada. J Cutan Med Surg 2018,22(2),244-245 · doi:10.1177/1203475417746126
- Li D.G.; Cohen J.M.; Mikailov A.; Williams R.F.; Laga A.C.; Mostaghimi A.; Clinical diagnostic accuracy of onychomycosis: A multispecialty comparison study. Dermatol Res Pract 2018,2018 · doi:10.1155/2018/2630176
- Nirmal B.; Utility of a multispectral dermatoscope in onychomycosis. Indian J Dermatol 2018,63(1),87-88 · doi:10.4103/ijd.ijd_37_17
- Bodman M.A.; Point-of-care diagnosis of onychomycosis by dermoscopy. J Am Podiatr Med Assoc 2017,107(5),413-418 · doi:10.7547/16-183
- De Crignis G.; Valgas N.; Rezende P.; Leverone A.; Nakamura R.; Dermatoscopy of onychomycosis. Int J Dermatol 2014,53(2),e97-e99 · doi:10.1111/ijd.12104
- Nargis T.; Pinto M.; Shenoy M.M.; Hegde S.; Dermoscopic features of distal lateral subungual onychomycosis. Indian Dermatol Online J 2018,9(1),16-19 · doi:10.4103/idoj.idoj_40_17
- Bertanha L.; Chiacchio N.D.; Nail clipping in onychomycosis. An Bras Dermatol 2016,91(5),688-690 · doi:10.1590/abd1806-4841.20164968
- Bet D.L.; Reis A.L.; Di Chiacchio N.; Belda W.; Dermoscopy and onychomycosis: Guided nail abrasion for mycological samples. An Bras Dermatol 2015,90(6),904-906 · doi:10.1590/abd1806-4841.20154615
- Kandi V.; Tungiasis presenting as onychomycosis: Probably the first report of flea infestation of the nail observed using modified potassium hydroxide mount technique. Cureus 2018,10(3) · doi:10.7759/cureus.2278
- Leung A.K.; Robson W.L.; Hair loss in children. J R Soc Health 1993,113(5),252-256 · doi:10.1177/146642409311300509
- Leung A.K.; Lam J.M.; Leong K.F.; Sergi C.M.; Melanonychia striata: Clarifying behind the black curtain. A review of clinical evaluation and management of the 21 century. Int J Dermatol 2019,58(11),1239-1245 · doi:10.1111/ijd.14464
- Oztürk Durmaz E.; Sezer E.; Dikicioğlu Çetin E.; Sahin S.; Onychomatricoma masquerading as candidal onychomycosis and paronychia. Acta Dermatovenerol Croat 2013,21(3),198-201
- Goldstein A.O.; Bhatia N.; Onychomycosis: Management. Post TW, ed UpToDate Waltham, MA. (Accessed on June 30, 2019).
- Ocampo-Garza J.; Di Chiacchio N.G.; Di Chiacchio N.; Machado-Filho C.D.; Acute transverse overcurvature of the nail due to onychomycosis. J Eur Acad Dermatol Venereol 2017,31(4),e202-e203 · doi:10.1111/jdv.13955
- Hanna S.; Andriessen A.; Beecker J.; Gilbert M.; Goldstein E.; Kalia S.; Clinical insights about onychomycosis and its treatment: A consensus. J Drugs Dermatol 2018,17(3),253-262
- Gupta A.K.; Paquet M.; Systemic antifungals to treat onychomycosis in children: A systematic review. Pediatr Dermatol 2013,30(3),294-302 · doi:10.1111/pde.12048
- Gupta A.K.; Mays R.R.; Versteeg S.G.; Shear N.H.; Friedlander S.F.; Onychomycosis in children: Safety and efficacy of antifungal agents. Pediatr Dermatol 2018,35(5),552-559 · doi:10.1111/pde.13561
- de Sá D.C.; Lamas A.P.; Tosti A.; Oral therapy for onychomycosis: An evidence-based review. Am J Clin Dermatol 2014,15(1),17-36 · doi:10.1007/s40257-013-0056-2
- Yadav P.; Singal A.; Pandhi D.; Das S.; Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial. Indian J Dermatol Venereol Leprol 2015,81(4),363-369 · doi:10.4103/0378-6323.158634
- Faergemann J.; Anderson C.; Hersle K.; Hradil E.; Nordin P.; Kaaman T.; Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol 1995,32(5 Pt 1),750-753 · doi:10.1016/0190-9622(95)91454-4
- Dhamoon R.K.; Popli H.; Gupta M.; Novel drug delivery strategies for the treatment of onychomycosis. Pharm Nanotechnol 2019,7(1),24-38 · doi:10.2174/2211738507666190228104031
- Piraccini B.M.; Tosti A.; Ciclopirox hydroxypropyl chitosan: Efficacy in mild-to-moderate onychomycosis. Skin Appendage Disord 2018,5(1),13-19 · doi:10.1159/000488606
- Canavan T.N.; Bevans S.L.; Cantrell W.C.; Wang C.; Elewski B.E.; Single-center, prospective, blinded study comparing the efficacy and compatibility of efinaconazole 10% solution in treating onychomycosis with and without concurrent nail polish use. Skin Appendage Disord 2018,5(1),9-12 · doi:10.1159/000488369
- Zeichner J.A.; Stein Gold L.; Korotzer A.; Penetration of ((14)C)-efinaconazole topical solution, 10%, does not appear to be influenced by nail polish. J Clin Aesthet Dermatol 2014,7(9),34-36
- Aly R.; Gupta A.K.; Winter T.; Zane L.T.; Vlahovic T.; Tavaborole in difficult-to-treat onychomycosis cases: A post-hoc assessment of Phase III subjects. J Drugs Dermatol 2017,16(10),1016-1021
- Krasaeath R.; Elizondo J.; Topical antifungals for treatment of onychomycosis. Am Fam Physician 2016,94(9),734
- Rich P.; Spellman M.; Purohit V.; Zang C.; Crook T.J.; Tavaborole 5% topical solution for the treatment of toenail onychomycosis in pediatric patients: Results from a Phase 4 open-label study. J Drugs Dermatol 2019,18(2),190-195
- Feng X.; Xiong X.; Ran Y.; Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review. Dermatol Ther 2017,30(3) · doi:10.1111/dth.12457
- Eichenfield L.F.; Friedlander S.F.; Pediatric onychomycosis: The emerging role of topical therapy. J Drugs Dermatol 2017,16(2),105-109
- Feldstein S.; Totri C.; Friedlander S.F.; Antifungal therapy for onychomycosis in children. Clin Dermatol 2015,33(3),333-339 · doi:10.1016/j.clindermatol.2014.12.010
- Gupta A.K.; Foley K.A.; Versteeg S.G.; Lasers for onychomycosis. J Cutan Med Surg 2017,21(2),114-116 · doi:10.1177/1203475416677722
- Abd El-Aal E.B.; Abdo H.M.; Ibrahim S.M.; Eldestawy M.T.; Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. J Dermatolog Treat 2019,30(3),277-282 · doi:10.1080/09546634.2018.1509046
- Bonhert K.; Dorizas A.; Sadick N.S.; Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd: YAG laser for treatment of toenail onychomycosis. J Cosmet Laser Ther 2019,21(3),179-183 · doi:10.1080/14764172.2018.1502451
- do Espírito Santo R.B.; Deps P.D.; Case study of onychomycosis patients treated with 1,064-nm Nd: YAG laser. Case Rep Dermatol 2018,10(2),216-225 · doi:10.1159/000492526
- Francuzik W.; Fritz K.; Salavastru C.; Laser therapies for onychomycosis - Critical evaluation of methods and effectiveness. J Eur Acad Dermatol Venereol 2016,30(6),936-942 · DOI
- Khater M.H.; Khattab F.M.; Combined long pulsed Nd-Yag laser and itraconazole versus itraconazole alone in the treatment of onychomycosis nails. J Dermatolog Treat 2019,3,1-19 · doi:10.1080/09546634.2019.1623861
- Okan G.; Tarikci N.; Gokdemir G.; The effect of long-pulsed Nd: YAG laser for the treatment of onychomycosis. J Am Podiatr Med Assoc 2017,107(1),54-59 · doi:10.7547/15-137
- Piccolo D.; Kostaki D.; Del Duca E.; Cannarozzo G.; Sannino M.; Nisticò S.; Long-pulsed 1064-nm Nd: YAG laser for the treatment of onychomycosis. Photomed Laser Surg 2017,35(4),213-216 · doi:10.1089/pho.2016.4153
- Rivers J.K.; Vestvik B.J.; Berkowitz J.; Real-world efficacy of 1064-nm Nd: YAG laser for the treatment of onychomycosis. J Cutan Med Surg 2017,21(2),108-113 · doi:10.1177/1203475416676804
- Weber G.C.; Firouzi P.; Baran A.M.; Bölke E.; Schrumpf H.; Buhren B.A.; Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: A single-center, retrospective analysis in 56 patients. Eur J Med Res 2018,23(1),53 · doi:10.1186/s40001-018-0340-y
- Wiznia L.E.; Quatrano N.A.; Mu E.W.; Rieder E.A.; A clinical review of laser and light therapy for nail psoriasis and onychomycosis. Dermatol Surg 2017,43(2),161-172 · doi:10.1097/dss.0000000000000841
- Zawar V.; Sarda A.; De A.; Clearance of recalcitrant onychomycosis following Q-switched Nd-Yag laser. J Cutan Aesthet Surg 2017,10(4),226-227 · doi:10.4103/jcas.jcas_18_17
- Zhou B.R.; Lu Y.; Permatasari F.; Huang H.; Li J.; Liu J.; The efficacy of fractional carbon dioxide (CO) laser combined with luliconazole 1% cream for the treatment of onychomycosis: A randomized, controlled trial. Medicine (Baltimore) 2016,95(44) · doi:10.1097/md.0000000000005141
- Gupta A.K.; Versteeg S.G.; A critical review of improvement rates for laser therapy used to treat toenail onychomycosis. J Eur Acad Dermatol Venereol 2017,31(7),1111-1118 · doi:10.1111/jdv.14212
- El-Tatawy R.A.; Aliweh H.A.; Hegab D.S.; Talaat R.A.Z.; Shams Eldeen M.A.; Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci 2019,34(9),1873-1880 · doi:10.1007/s10103-019-02789-2
- Morgado L.F.; Trávolo A.R.F.; Muehlmann L.A.; Narcizo P.S.; Nunes R.B.; Pereira P.A.G.; Photodynamic therapy treatment of onychomycosis with aluminium-phthalocyanine chloride nanoemulsions: A proof of concept clinical trial. J Photochem Photobiol B 2017,173,266-270 · doi:10.1016/j.jphotobiol.2017.06.010
- Alberdi E.; Gómez C.; Efficiency of methylene blue-mediated photodynamic therapy vs. intense pulsed light in the treatment of onychomycosis in the toenails. Photodermatol Photoimmunol Photomed 2019,35(2),69-77 · doi:10.1111/phpp.12420
- Bhatta A.K.; Keyal U.; Wang X.L.; Photodynamic therapy for onychomycosis: A systematic review. Photodiagn Photodyn Ther 2016,15,228-235 · doi:10.1016/j.pdpdt.2016.07.010
- Bristow I.; Baran R.; Score M.; Rapid treatment of subungual onychomycosis using controlled micro nail penetration and terbinafine solution. J Drugs Dermatol 2016,15(8),974-978
- Shemer A.; Gupta A.K.; Babaev M.; Barzilai A.; Farhi R.; Daniel Iii C.R.; A retrospective study comparing K101 nail solution as a monotherapy and in combination with oral terbinafine or itraconazole for the treatment of toenail onychomycosis. Skin Appendage Disord 2018,4(3),166-170 · doi:10.1159/000484211
- Repka M.A.; Mididoddi P.K.; Stodghill S.P.; Influence of human nail etching for the assessment of topical onychomycosis therapies. Int J Pharm 2004,282(1-2),95-106 · doi:10.1016/j.ijpharm.2004.06.010
- Kushwaha A.; Shivakumar H.N.; Murthy S.N.; Iontophoresis for drug delivery into the nail apparatus: Exploring hyponychium as the site of delivery. Drug Dev Ind Pharm 2016,42(10),1678-1682 · doi:10.3109/03639045.2016.1165690
- Lipner S.R.; Scher R.K.; Management of onychomycosis and co-existing tinea pedis. J Drugs Dermatol 2015,14(5),492-494
- Scher R.K.; Tosti A.; Joseph W.S.; Vlahovic T.C.; Plasencia J.; Markinson B.C.; Onychomycosis diagnosis and management: Perspectives from a joint dermatology-podiatry roundtable. J Drugs Dermatol 2015,14(9),1016-1021
- Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure Dermatol Ther 30(5).2017 · doi:10.1111/dth.12545
- Tosti A.; Elewski B.E.; Onychomycosis: Practical approaches to minimize relapse and recurrence. Skin Appendage Disord 2016,2(1-2),83-87 · doi:10.1159/000448056
- Kemna M.E.; Elewski B.E. A U.S.; epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996,35(4),539-542 · doi:10.1016/s0190-9622(96)90675-1
- Al-Hatmi A.M.; Bonifaz A.; Calderón L.; Curfs-Breuker I.; Meis J.F.; van Diepeningen A.D.; Proximal subungual onychomycosis caused by Fusarium falciforme successfully cured with posaconazole. Br J Dermatol 2015,173(1),253-255 · doi:10.1111/bjd.13589
- Lipner S.R.; Friedman G.; Scher R.K.; Pilot study to evaluate a plasma device for the treatment of onychomycosis. Clin Exp Dermatol 2017,42(3),295-298 · doi:10.1111/ced.12973
- Heinlin J.; Maisch T.; Zimmermann J.L.; Shimizu T.; Holzmann T.; Simon M.; Heider J.; Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment. Future Microbiol 2013,8(9),1097-1106 · doi:10.2217/fmb.13.86
- Sonthalia S.; Jakhar D.; Yadav P.; Kaur I.; Chemical peeling as an innovative treatment alternative to oral antifungals for onychomycosis in special circumstances. Skin Appendage Disord 2019,5(3),181-185 · doi:10.1159/000495152
- Krainbring V.G.A.; Composition for treating onychomycosis.WO2019105793 (2019). · DOI
Metadata
- Authors
- Leung, A. K. C., Lam, J. M., Leong, K. F., Hon, K. L., Barankin, B., Leung, A. A. M., & Wong, A. H. C.
- Venue
- Recent Patents on Inflammation & Allergy Drug Discovery
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2020-03-30
- Volume
- 14
- Issue
- 1
- Pages
- 32-45
- ISSN
- 1872-213X (ISSN-L)
- OpenAlex
- W2983564427
- Cited by
- 187
- References
- 60
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Onychomycosis: An Updated Review. https://app.cochat.ai/papers/10.2174/1872213x13666191026090713
- The paper
- Leung, A. K. C., Lam, J. M., Leong, K. F., Hon, K. L., Barankin, B., Leung, A. A. M., & Wong, A. H. C. (2020). Onychomycosis: An Updated Review. Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/1872213x13666191026090713
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.